Johannes A. Eble

Univ.-Prof. Dr. rer. nat. Johannes A. Eble serves as the Head of the Institute of Physiological Chemistry and Pathobiochemistry at the University of Münster. His academic journey includes a PhD in Biochemistry from Ludwig Maximilians University of Munich and postdoctoral research at Harvard Medical School and the Max Planck Institute. He has held leadership roles in prestigious institutions like the Excellence Cluster Cardio-Pulmonary System and the CiM Cluster of Excellence.

Research focuses on integrin-mediated cell-ECM interactions in vascular systems, with expertise in collagen and laminin binding, platelet biology, and snake venom pharmacology. His work bridges basic science and translational applications, including anticoagulant therapies and anticancer targets.

Key achievements include the discovery of integrin antagonists in snake venoms and the role of CLEC-2 in hemostasis. He leads a lab with 15+ publications annually, including seminal studies in Journal of Biological Chemistry and Matrix Biology. Awards include the Otto Hahn Medal and the Technology Transfer Prize.

• Education: PhD (1994), Habilitation (2004)
• Grants: Collaborative Research Centers (SFBs) 492, 815, TR23, 1009
• Collaborations: CiMIC, Excellence Clusters, and international networks

Labs: AG Eble Lab (Physiological Chemistry) and Multiscale Imaging Centre collaborations. Training over 20 PhD/master students and alumni in matrix biology and vascular research.